Stay updated on Epacadostat & Pembrolizumab in GIST Clinical Trial
Sign up to get notified when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.

Latest updates to the Epacadostat & Pembrolizumab in GIST Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedUpdated operating status notice and added version 3.2.0; removed the GI stromal tumor resource (from the Genetic and Rare Diseases Information Center) and the prior version tag v3.1.0.SummaryDifference3%
- Check15 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.1%
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2 and the 'Back to Top' element was removed. Overall, there are no significant changes to core content, pricing, or availability.SummaryDifference0.2%
- Check37 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.2%
- Check44 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as specific drug names related to gastrointestinal stromal tumors, while also removing several related terms and previous location details.SummaryDifference1%
- Check58 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Epacadostat & Pembrolizumab in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.